Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma-Reference-Cited by-同舟云学术

Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma

Published:2016-04-01 Issue:4 Volume:152 Page:452
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Ally Mina S.¹,Ransohoff Katherine²,Sarin Kavita¹,Atwood Scott X.³,Rezaee Melika¹,Bailey-Healy Irene¹,Kim Jynho³,Beachy Philip A.³,Chang Anne Lynn S.¹,Oro Anthony²,Tang Jean Y.¹,Colevas A. Dimitrios⁴

Affiliation:

1. Department of Dermatology, Stanford University, Stanford, California

2. Department of Dermatology, Stanford University, Stanford, California2Department of Dermatology, School of Medicine, Stanford University, Stanford, California

3. Department of Dermatology, School of Medicine, Stanford University, Stanford, California

4. Cancer Center, Stanford University, Stanford, California

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment Options;Biomedicines;2024-06-28

2. Basal Cell Carcinoma;Rook's Textbook of Dermatology;2024-03-19

3. Upregulation of apoptotic genes and downregulation of target genes of Sonic Hedgehog signaling pathway in DAOY medulloblastoma cell line treated with arsenic trioxide;Journal of Chemotherapy;2023-12-22

4. Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy;MedComm;2023-12

5. Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors;Annals of Oncology;2023-12